Department of Radiation Oncology, Henry Ford Health System, Detroit, MI 48202, USA.
Phys Med Biol. 2012 Sep 7;57(17):5361-79. doi: 10.1088/0031-9155/57/17/5361. Epub 2012 Aug 3.
The cone-beam computed tomography (CBCT) imaging modality is an integral component of image-guided adaptive radiation therapy (IGART), which uses patient-specific dynamic/temporal information for potential treatment plan modification. In this study, an offline process for the integral component IGART framework has been implemented that consists of deformable image registration (DIR) and its validation, dose reconstruction, dose accumulation and dose verification. This study compares the differences between planned and estimated delivered doses under an IGART framework of five patients undergoing prostate cancer radiation therapy. The dose calculation accuracy on CBCT was verified by measurements made in a Rando pelvic phantom. The accuracy of DIR on patient image sets was evaluated in three ways: landmark matching with fiducial markers, visual image evaluation and unbalanced energy (UE); UE has been previously demonstrated to be a feasible method for the validation of DIR accuracy at a voxel level. The dose calculated on each CBCT image set was reconstructed and accumulated over all fractions to reflect the 'actual dose' delivered to the patient. The deformably accumulated (delivered) plans were then compared to the original (static) plans to evaluate tumor and normal tissue dose discrepancies. The results support the utility of adaptive planning, which can be used to fully elucidate the dosimetric impact based on the simulated delivered dose to achieve the desired tumor control and normal tissue sparing, which may be of particular importance in the context of hypofractionated radiotherapy regimens.
锥形束计算机断层扫描(CBCT)成像是图像引导自适应放射治疗(IGART)的一个组成部分,它使用患者特定的动态/时间信息来进行潜在的治疗计划修改。在这项研究中,实现了一个完整的 IGART 框架的离线处理过程,包括变形图像配准(DIR)及其验证、剂量重建、剂量积累和剂量验证。本研究比较了 5 例前列腺癌放射治疗患者在 IGART 框架下计划剂量和估计剂量之间的差异。通过在 Rando 骨盆体模中进行测量,验证了 CBCT 上剂量计算的准确性。通过三种方法评估患者图像集上 DIR 的准确性:使用基准标记的标记匹配、视觉图像评估和不平衡能量(UE);UE 之前已被证明是在体素水平验证 DIR 准确性的一种可行方法。在每个 CBCT 图像集上计算的剂量进行重建并在所有分次中累积,以反映实际给予患者的“实际剂量”。然后将可变形累积(交付)的计划与原始(静态)计划进行比较,以评估肿瘤和正常组织剂量差异。结果支持自适应计划的实用性,这可以用于根据模拟的交付剂量充分阐明剂量学影响,以实现预期的肿瘤控制和正常组织保护,这在短程放疗方案中可能尤为重要。